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Purpose: To develop an internal target volume (ITV) margin determination framework (or
decision-supporting framework) for treating multiple lung metastases using CyberKnife
Synchrony with intraoperatively implanted fiducial markers (IIFMs). The feasibility of using
non-ideally implanted fiducial markers (a limited number and/or far from a target) for
tracking-based lung stereotactic ablative radiotherapy (SABR) was investigated.
Methods: In the developed margin determination framework, an optimal set of IIFMs was
determined to minimize a tracking uncertainty-specific ITV (ITVtracking) margin (margin
required to cover target-to-marker motion discrepancy), i.e., minimize the motion
discrepancies between gross tumor volume (GTV) and the selected set of fiducial
markers (FMs). The developed margin determination framework was evaluated in 17
patients with lung metastases. To automatically calculate the respiratory motions of the
FMs, a template matching-based FM tracking algorithm was developed, and GTV motion
was manually measured. Furthermore, during-treatment motions of the selected FMs
were analyzed using log files and compared with those calculated using 4D CTs.
Results: For 41 of 42 lesions in 17 patients (97.6%), an optimal set of the IIFMs was
successfully determined, requiring an ITVtracking margin less than 5 mm. The template
matching-based FM tracking algorithm calculated the FM motions with a sub-millimeter
accuracy compared with the manual measurements. The patient respiratory motions
during treatment were, on average, significantly smaller than those measured at simulation
for the patient cohort considered.
Conclusion: Use of the developed margin determination framework employing
CyberKnife Synchrony with a limited number of IIFMs is feasible for lung SABR.
Keywords: lung metastasis, intraoperative fiducial marker implantation, CyberKnife Synchrony, fiducial tracking,
internal target volume, stereotactic ablative radiotherapyOctober 2021 | Volume 11 | Article 7532461
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CyberKnife Synchrony, a fiducial-based tracking method, is an
attractive radiation treatment (RT) modality with CyberKnife’s
dosimetric advantages due to non-coplanar delivery of radiation
doses (1). In general, CyberKnife Synchrony requires fiducialmarker
(FM) implantation prior to RT simulation and planning, which is
mainly performed via a percutaneous, computed tomography (CT)-
guided insertion procedure. Moreover, FMs can be inserted during
surgery (2). IntraoperativeFMimplantationcanbebeneficial in some
clinical situations, in which the extent of surgery is limited by
concerns on morbidity or pulmonary function. In this case, the
remaining unresectable lesions can be treated via stereotactic ablative
radiotherapy (SABR) with intraoperatively implanted FMs (IIFMs).
Furthermore, when a “missing lesion” exists (3), which is not
detectable during surgery, FMs can be intraoperatively implanted
and used for the following SABR. In addition to the use of IIFMs,
existing FMs that were used in previous treatments can be further
utilized for additional RT.
These challenging clinical scenarios, inwhich a limitednumber of
FMs are available, including those located far from a target, pose the
following clinical questions because inserting three to five FMs near
each radiation target is ideal for the CyberKnife fiducial tracking-
based RT: 1) which among the various RT techniques, including
CyberKnife fiducial tracking, respiratory gating, and internal target
volume (ITV)-based technique, is the optimal treatment?, 2) if a
lesion is treated using CyberKnife fiducial tracking, how can the
uncertainty related to motion discrepancy between the target and
existing FMs be quantified for consideration in treatment planning?
Therefore, to address the aforementioned and unanswered
questions, we aimed to develop a margin determination
framework (a decision-supporting framework) and evaluate its
clinical feasibility. Specifically, this study evaluated the feasibility
of using the developed margin determination framework for
treating multiple lung metastases using IIFMs. To the best of the
authors’ knowledge, this study is the first tomake an effort towards
developing such a novel framework, which has the potential to
facilitate usage of non-ideally implanted FMs for tracking-based
RT, thereby reducing the risk of side effects by additional FM
implantation. Furthermore, successful implementation of the
developed framework can facilitate multi-site SABR using a
limited number of FMs as dynamic transition into repeat
oligometastatic and induced oligometastatic diseases may be
possible depending on the response to local or systemic therapy (4).
METHODS AND MATERIALS
ITVtracking Margin Determination Framework
The developed margin determination framework was designed
to 1) analyze the motions of a radiation target and IIFMs,Abbreviations: ITV, internal target volume; IIFM, intraoperatively implanted
fiducial marker; SABR, stereotactic ablative radiotherapy; FM, fiducial marker; CT,
computed tomography; I-S, inferior-superior; CPAP, continuous positive airway
pressure; GTV, gross tumor volume; CK, CyberKnife; R-L, right-left; A-P,
anterior-posterior; VMAT, volumetric-modulated arc therapy; PTV, planning
target volume.
Frontiers in Oncology | www.frontiersin.org 22) evaluate the motion synchronization level between the
target and all possible sets of the IIFMs, and 3) suggest an
optimal FM set S* showing maximum synchronization with an
additional margin required to cover the target-to-marker motion
discrepancy. This additional margin is referred to as “tracking
uncertainty-related ITV (ITVtracking) margin” in this study.
The margin determination framework was developed using
MATLAB (MathWorks, Natick, MA, USA). The steps in the
developed framework can be mathematically formulated
as follows:
S* = argmin f (S), S ⊂ 1, 2, :::,NFf g (1)
f (S) = jj uT − uS jj2 (2)
where f(S) represents the root mean square difference between
the target motion uT and the average motion uS of a subset of the
FMs S, and NF represents the number of the IIFMs. Finally,
ITVtracking margin is defined as follows:
ITVtracking margin = jj uT − uS∗ jj (3)
Fiducial Marker Tracking Algorithm
A template matching-based registration algorithm was
developed to calculate the motions of each of the IIFMs in 4D
CT using ITK (5). FMs were initially detected by thresholding
HU values (HU > 1500). Then, a template matching algorithm
was used to find an optimal translation vector that maximizes a
mutual information (6–8) between the reference (0% phase) and
target (10–90% phases) images. A template was defined as a
cubic region of 4 × 4 × 10 mm3 centered at the detected FM on
the reference image; the dimension of the cubic region-of-
interest was optimally determined by a parametric study.
Multi-resolution template matching was performed by starting
with a grid size of 1.0 mm and reducing the grid spacing to
0.25 mm.
Phantom Study
A phantom study was conducted to evaluate the feasibility of
using 4D CT and the developed registration-based FM tracking
method for the calculation of FM motion. The FM motions on
4D CT images were analyzed using two methods, manual and
automatic (template matching-based), and were compared with
the known motions. A Quasar Respiratory Motion Phantom
(Modus QA, London, Ontario, Canada) was used to simulate a
respiratory motion (9), expressed by z(t) = z0 – b cos
4(pt/t),
where z(t) and z0 represent the inferior-superior (I-S) location of
the target at time t and initial position, respectively, b represents
the peak-to-peak motion amplitude, and t represents the
respiration cycle (b = 5, 10, 15, and 20 mm; t = 4 s). Three
gold FMs (approximately 1 mm diameter and 3 mm length) were
inserted into a Cedar Lung Tomour Insert (Modus QA, London,
Ontario, Canada). Ten-phase 4D CTs of the phantom were
acquired using a Toshiba Aquilion CT simulator (Toshiba
Medical System, Japan) and Abches (APEX Medical, Inc.,
Japan), a respiration-monitoring device, with a slice thickness
of 3 mm. It is noted that this 4D CT acquisition protocol used forOctober 2021 | Volume 11 | Article 753246
Kim et al. Margin Determination Frameworkthe phantom was the same as that in the patient 4D
CT acquisition.
Patient Study
Seventeen patients with lung metastases and IIFMs were
considered for a retrospective analysis approved by the
institutional review board of Severance Hospital, Seoul, South
Korea (4-2021-0440). Characteristics of the patients are
summarized in Table 1. The number of lung lesions varied
among the patients (range: 1 to 9). Two to six FMs (median: 5)
were implanted for each patient during surgery performed prior
to the RT of the lung metastases. Maximally, three FMs were
implanted into each side of the lungs, resulting in a total of six
FMs. Figure 1 presents a patient case with six IIFMs. As
illustrated in Figure 1, in general, one FM was implanted into
each of the upper, middle, and lower lobes on each side the lungs
(in total, 73 IIFMs for 17 patients). Lung lesions of the patient
cohort were treated with one of the following dose-fractionation
schemes: 20 Gy × 1, 25 Gy × 1, 30 Gy × 1, 18 Gy × 3, and 6 Gy ×
5. Continuous positive airway pressure (CPAP) with a pressure
of 12-17 cmH2O (median: 15 cmH2O) was used for respiration
motion management as it has been shown to effectively reduce
radiation dose to the lung (10–12).
The developed margin determination framework was tested
for the patient data. For each of the lung targets, the motion-to-
marker motion discrepancies were analyzed, finally resulting in
an optimal set of IIFMs with a corresponding ITVtracking margin.
The accuracy of the developed FM tracking algorithm was
evaluated by comparing the automatically registered motions
with the manually measured motions for all the 73 FMs.
The feasibility of the developed margin determination
framework was further evaluated by comparing the motions of
the IIFMs calculated using the 4D CT with the in-treatment
motions calculated using treatment log files. Using the three-Frontiers in Oncology | www.frontiersin.org 3dimensional coordinates of the FMs tracked during the
treatment beam delivery (average motion of the FMs), motion
amplitudes during each treatment fraction were calculated. A
paired two-tailed t-test with 95% confidence was conducted
using MATLAB to evaluate the hypothesis that the
pretreatment and average in-treatment motions of the FMs
were statistically different.RESULTS
ITVtracking Margin Calculation
Figure 2A illustrates how the developed framework determined
an optimal FM set with a minimal ITVtracking margin.
Consequently, for patient 5, to treat the GTV with the FM R2,
ITVtracking margins of 0.5, 2.7, and 2.7 mmwere required to cover
the GTV-to-marker motion discrepancies in the right-left (R-L),
anterior-posterior (A-P), and I-S directions, respectively.
The ITVtracking margins calculated across all of the lung
lesions were 1.0 ± 0.8, 1.1 ± 1.2, and 1.8 ± 1.7 mm in the R-L,
A-P, and I-S directions, respectively (see Figures 2B–D). Of the
42 lung lesions, only one required an ITVtracking margin larger
than 5 mm (8.4 mm in the I-S direction for patient 7). This lesion
was treated with a volumetric-modulated arc therapy (VMAT)
plan with the ITV technique. Detailed information (selected
FMs, corresponding ITVtracking margins, and GTV-to-marker
distances) of the ITVtracking determination results for all lung
lesions is summarized in Table 2. The GTV-to-marker distance
was 59.3 ± 24.6 mm.
The locations of the IIFMs for each patient are shown in a
coronal view in Figure 3. In Figure 4, the locations of the IIFMs
for all patients are approximately plotted with the lungs of
representative dimensions and are color-coded depending on
the FM motion amplitudes.TABLE 1 | Summary of patient characteristics.
Patient # Number of GTVs Number of fiducial markers Number of CK plans Number of log-available CK plans
Right Left Total Right Left Total
1 6 3 9 3 2 5 9 8
2 1 0 1 3 0 3 1 1
3 0 2 2 3 2 5 2 2
4 0 1 1 3 2 5 1 1
5 1 0 1 2 2 4 1 1
6 4 0 4 3 3 6 4 3
7 1 0 1 2 1 3 0 0
8 3 1 4 2 1 3 4 3
9 2 0 2 2 2 4 2 2
10 1 0 1 1 1 2 1 0
11 1 1 2 2 2 4 2 2
12 1 0 1 3 0 3 1 1
13 1 0 1 3 2 5 1 1
14 2 2 4 3 3 6 4 4
15 1 0 1 3 2 5 1 1
16 4 1 5 3 2 5 5 1
17 2 0 2 3 2 5 2 0
Total 31 11 42 44 29 73 41 31OctobeGTV, gross tumor volume; CK, CyberKnife.r 2021 | Volume 11 | Article 753246
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Phantom
Figure 5 presents the comparison results of the FM motions
calculated using manual and automatic localization methods
with the ground truth motions. The manually segmented and
registered motions agreed reasonably well with each other,
resulting in a difference of 0.2 ± 0.2 mm. The automatically
measured motions were smaller than the ground truth motions
by, on average, 0.5, 0.3, 0.5, and 1.8 mm for the 5-, 10-, 15-, and
20-mm reference motions, respectively.
Accuracy of Fiducial Tracking Algorithm:
Patient
The registration errors, which were calculated as the difference
between the registered and manually segmented FM positions,
are plotted as histograms in Figure 6. The absolute registration
errors were 0.1 ± 0.1, 0.1 ± 0.1, and 0.3 ± 0.3 mm in the R-L, A-P,
and I-S directions, respectively, in all patients. In 12 (1.8%) of the
657 alignments, the registration error was larger than 2 mm inFrontiers in Oncology | www.frontiersin.org 4the I-S direction. These relatively large misalignments occurred
for the image registrations from 0% to intermediate phases where
FMs quickly moved and are thereby abnormally displayed.
The differences between the motion amplitudes that were
manually measured and calculated using the template matching
algorithm across all the FMs of patients were 0.1 ± 0.1 (range:
−0.6 to 0.6), 0.1 ± 0.1 (−0.5 to 0.5), and 0.2 ± 0.2 (−0.9 to 0.9) mm
in the R-L, A-P, and I-S directions, respectively.
Log-Based In-Treatment Motion Analysis
Figure 7 presents paired box plots comparing the pretreatment and
mean in-treatment motion amplitudes, which were analyzed using
4D CT and the treatment log file, respectively. The mean in-
treatment motion amplitudes were smaller than the pretreatment
motion amplitudes, resulting in statistically significant differences
of−0.5 ± 0.5,−1.1 ± 1.3, and −1.0 ± 2.0mm in the R-L, A-P, and I-S
directions, respectively (p < 0.005 in all directions).DISCUSSION
This study demonstrated the feasibility of using the developed
ITVtracking margin determination framework to aid in the
decision-making process of treating multiple lung metastases
using IIFMs. An optimal set of IIFMs was successfully
determined for each of the GTV of the patient cohort. An
ITVtracking margin of less than 5 mm was required for 41 of 42
patients to cover the motion discrepancy between the GTV and
selected FMs. Patient 1, in whom nine lung lesions were defined, is
the best example that shows the effectiveness of the IIFM-based RT
technique. Without the insertion of FMs during surgery, treating
this large number of lung metastases was not practically feasible,
requiring implantation of at least 27 FMs for an ideal tracking.
However,with thedeveloped framework, nine lungmetastaseswere
treated with only five IIFMs by introducing reasonable margins.
To the best of our knowledge, this study is the first to develop an
innovative margin determination framework that can facilitate
SABR of multiple lung metastases using IIFMs although the
clinical relevance of these results is yet to be elucidated and will
be reported separately. This novel development suggests a
technological combination that supports a challenging treatment,
which is performed mainly in an oligo-metastatic setting. First, as
suggested by Pop et al. (2), FM placement during surgery can be a
promising method to treat potential local recurrence without
percutaneous or bronchoscopic insertion. Second, treating
multiple lung metastases can be further supported by superior
dosimetric characteristics (1) of the CyberKnife plans because of its
non-coplanar beam arrangement. Finally, CPAP can reduce the
radiation dose to the lungs (10–12). The combination of the
aforementioned treatment techniques can facilitate the ablative
treatment of multiple lung metastases.
Both phantom and patient studies demonstrated that gold
FMs can be localized using the developed fiducial tracking
algorithm with a sub-millimeter accuracy despite the limited
resolution of 4D CT images (3 mm slice thickness in this study).
The motions calculated using the template matching-based
fiducial tracking algorithm closely coincided with those manuallyFIGURE 1 | Example of intraoperatively implanted fiducial markers (six
markers for patient 14), each of which is displayed at the center of the axial
(first column from left), sagittal (second), and coronal (third) views.October 2021 | Volume 11 | Article 753246
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FIGURE 2 | ITVtracking determination results: (A) illustrative example of the processing to optimally select a fiducial marker (FM) set with a minimal ITVtracking margin
by comparing the motions of the GTV and all possible sets of the fiducial markers, (B–D) histograms of the ITVtracking margins (i.e., the motion differences between
the gross tumor volume and optimally selected FM set) calculated across 42 lung lesions from 17 patients in the (B) R-L, (C) A-P, and (D) I-S directions, respectively.
ITV, internal target volume; R-L, right-left; A-P, anterior-posterior; I-S, inferior-superior; CK, CyberKnife.TABLE 2 | Summary of the ITVtracking determination results for each of the 42 lung lesions for 17 patients.
Patient # GTV # Optimal FM set ITVtracking margin (mm) GTV-to-FM distance (mm)
R-L A-P I-S
1 Right 1 R3 0.7 0.2 1.0 30.9
2 R2, R3 1.4 0.9 0.6 69.7, 20.3
3 R2, R3 0.9 0.6 0.7 42.7, 33.9
4 R1 1.2 2.8 3.8 103.7
5 R2, R3 1.3 0.5 0.8 18.7, 68.5
6 R1, R2 1.0 0.7 1.3 90.4, 38.8
Left 1 L1, L2 3.2 0.9 0.3 52.7, 59.3
2 L1, L2 0.7 0.8 2.0 100.8, 11.1
3 L2 3.3 4.1 4.3 42.0
2 Right 1 R2 0.4 0.1 0.4 67.9
3 Left 1 L1 0.9 1.9 2.1 39.4
2 L1 1.0 1.2 2.9 63.0
4 Left 1 L2 1.2 0.2 2.9 20.8
5 Right 1 R2 0.5 2.7 2.7 41.5
6 Right 1 R1 0.8 0.1 4.8 45.5
2 R1, R2 1.5 0.8 0.4 128.5, 52.6
3 R3 0.3 0.1 4.9 55.6
4 R2 0.4 0.2 0.4 47.9
7 Right 1 R2 0.4 1.1 8.4 52.4
8 Right 1 R1, R2 1.3 1.5 3.4 55.3, 66.8
2 R1 1.0 0.5 0.2 69.2
3 R1 0.3 0.5 0.8 82.4
Left 1 L1 1.0 1.5 0.1 42.8
9 Right 1 R1, R2 0.1 1.7 0.5 59.3, 123.8
2 R1, R2 0.9 0.0 0.4 80.9, 91.5
10 Right 1 R1 0.6 4.2 3.8 57.5
11 Right 1 R1 0.1 0.5 4.4 96.6
Left 1 L1, L2 1.8 0.3 1.0 19.5, 45.0
12 Right 1 R1 0.7 0.0 0.7 20.5
(Continued)Frontiers in Oncology | www.frontiersin.org October 2021 |5 Volume 11 | Article 753246
Kim et al. Margin Determination Frameworkmeasured. However, as demonstrated in the phantom study, the
motions captured in the 4D CT images (both manually and
automatically detected) were similar to but slightly smaller than
the ground truth motions. This motion underestimation by 4D CT
may be attributed to the motion uncertainty in the phantom. For
example, the insert of the phantom containing the FMs was
measured to move approximately 19 mm although a motion of
20 mmwas simulated. In addition, motion underestimation by 4D
CTwas reported in a recent study (13).As this investigation focused
on the synchronization level between the lung target and IIFMs,
underestimation of the respiration motions by 4D CT images may
not greatly affect the resulting ITVtracking margin size.
The consistency of the FM motions between simulation and
treatment was evaluated using the log file information. The average
in-treatment FM motions were significantly smaller than thoseFrontiers in Oncology | www.frontiersin.org 6simulated using the planning 4DCT images. Assuming a consistent
synchronization between the target and selected FMs, a smaller
motion for GTVs can be theoretically expected and, therefore, a
smaller motion discrepancy. In addition, relatively large standard
deviations of the intrafractionmotion amplitudes indicated that the
patient breathed with various amplitudes over the long treatment
duration with CyberKnife. Given that the in-treatment motion
amplitudes were larger compared with plannedmotion amplitudes
for a small portion of the total treatment time, only a small amount
of target miss is expected in the treatment using a selected set of the
IIFMs. However, additional margin may be necessary to
compensate for further motion discrepancies that possibly occur
during treatment.
Careful attention should be paid to planning target volume
(PTV) margin determination and patient setup when theTABLE 2 | Continued
Patient # GTV # Optimal FM set ITVtracking margin (mm) GTV-to-FM distance (mm)
R-L A-P I-S
13 Right 1 R2, R3 2.9 0.5 2.6 75.8, 63.4
14 Right 1 R3 0.9 0.9 1.2 24.0
2 R1, R2 0.7 3.6 1.3 86.9, 52.4
Left 1 L2 0.2 0.5 0.7 19.6
2 L2 1.6 0.2 0.7 65.2
15 Right 1 R2, R3 0.1 0.2 1.1 31.5, 39.9
16 Right 1 R1, R2 0.4 0.7 0.7 120.1, 66.9
2 R1, R2 1.2 0.3 0.8 132.2, 85.4
3 R3 0.4 1.3 1.4 44.2
4 R1, R2 1.3 0.1 0.8 146.0, 49.5
Left 1 L1 1.7 2.3 1.4 43.3
17 Right 1 R2 0.2 4.4 1.2 92.0
2 R1 0.5 1.8 0.8 81.2
Mean 1.0 1.1 1.8 59.3
Standard deviation 0.8 1.2 1.7 24.6October 2021 |The fiducial markers were numbered in the superior-inferior direction; for instance, R1 represents the fiducial marker on the right side, which is the most superiorly located.
GTV, gross tumor volume; FM, fiducial marker; R, right; L, left.FIGURE 3 | Graphical representation of the location of the intraoperatively implanted fiducial markers on coronal view for each of the 17 patients.Volume 11 | Article 753246
Kim et al. Margin Determination FrameworkCyberKnife Synchrony tracking is used to treat a lung target with
fewer FMs than those recommended by the vendor. In particular,
with one FM tracked, a small rotation may result in a large
displacement of the lung target from the planned position.
Therefore, an appropriate selection of PTV margin and/or
accurate patient setup are required for the suggested treatment
technique. In this study, when the calculated ITVtracking margin
was less than 5 mm, a uniform CTV-to-PTV margin of 5–8 mm
was applied. Further investigation is warranted for this purpose.Frontiers in Oncology | www.frontiersin.org 7Furthermore, a dosimetric comparison between the proposed
tracking radiation therapy and VMAT plans needs to be
performed with careful consideration on PTV margins for both
treatment techniques. A CyberKnife Synchrony plan with an
appropriate ITVtracking and PTV margins can be dosimetrically
advantageous over a VMAT plan when the patient respiratory
motion is relatively large, resulting in a larger target volume for
VMAT. When CyberKnife Synchrony and VMAT are available
for lung SBRT, a decision-making process should be supportedA B C
FIGURE 4 | Approximate locations and motion amplitudes (color-coded) in the (A) R-L, (B) A-P, and (C) I-S directions for all the intraoperatively implanted fiducial
markers for 17 patients. R-L, right-left; A-P, anterior-posterior; I-S, inferior-superior.FIGURE 5 | Comparison of the automatically and manually measured motions (0% to the other respiratory phases) of the three fiducial markers inserted into the
Quasar phantom with the ground truth motions.A B C
FIGURE 6 | Histograms of the all-phase fiducial marker registration errors by the template matching-based image registration performed for the patient data in the
(A) R-L, (B) A-P, and (C) I-S directions. R-L, right-left; A-P, anterior-posterior; I-S, inferior-superior.October 2021 | Volume 11 | Article 753246
Kim et al. Margin Determination Frameworkby evaluation of dosimetric benefits. Finally, a long-term report
on treatment outcomes and toxicity will be required to provide
evidence for the proposed treatment approach.CONCLUSIONS
The feasibility of using the developed margin determination
framework for SABR of multiple lung metastases using IIFMs was
demonstrated.With careful consideration of accurate patient setup
and appropriate selection of PTV margin, the developed margin
determination framework can be successfully used to deliver local
ablative dose to multiple lung metastases.DATA AVAILABILITY STATEMENT
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